Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: A randomized Phase III trial of the International Atomic Energy Agency (IAEA)

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 3, 2001, Pages 765-775

  Salazar, Omar M ^a   Sandhu, Talgit ^a   Da Motta, Neiro W ^b   Escutia, María Ángeles Perez ^c   Lanzós Gonzales, Eduardo ^c   Mouelle Sone, A ^d   Moscol, Alfredo ^e   Zaharia, Mayer ^e   Zaman, Shamas ^f  

^a Oakwood Healthcare Inc   (United States)

^b HOSPITAL SANTA RITA   (Brazil)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d YAOUNDÉ GENERAL HOSPITAL   (Cameroon)

^e INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^f Institute of Nuclear Medicine and Oncology INMOL   (Pakistan)

Author keywords

Bone metastases; Half body irradiation; Pain palliation; Quality of life; Widespread metastatic cancer

Indexed keywords

BONE; IRRADIATION; TOXICITY; TUMORS;

METASTATIC BONE CANCER;

ONCOLOGY;

NARCOTIC AGENT;

ABDOMINAL PAIN; ANEMIA; ARTICLE; BLOOD CELL COUNT; BONE METASTASIS; BREAST CANCER; CANCER PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSIMETRY; HALF-BODY IRRADIATION; HUMAN; LEUKOPENIA; LUNG CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PALLIATIVE THERAPY; PERFORMANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; STATISTICAL ANALYSIS; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

BONE NEOPLASMS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HEMIBODY IRRADIATION; HUMANS; MALE; PAIN; PALLIATIVE CARE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0035400467     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01495-X     Document Type: Article

References (41)

1. Radiotherapy for cancer pain management
2. Bone metastases; Pathophysiology and management policy
3. The influence of national attitudes on the use of radiotherapy in advanced and metastatic cancer, with particular reference to differences between the United Kingdom and the United States of America; Implications for future studies
4. Metastatic bone disease; Current concepts of clinicopathophysiology and modern surgical treatment
5. Stage IV breast cancer; Clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis
6. Metastatic breast cancer confined to the skeletal system
7. Palliation of bone metastases
8. Carcinoma of the prostate; Correlation between radiologic quantification of metastases and patient survival
9. Stratifification of patients with metastatic prostate cancer based on the extent of disease on initial bone scan
10. Fractionated half-body irradiation for pain palliation in widely metastatic cancers; Comparison with single dose
11. Half-body radiotherapy of advanced cancer
12. Systemic (half-body) radiation therapy; Response and toxicity
13. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors-Final Radiation Therapy Oncology Group report
14. Radiation therapy new approaches
15. Theoretical and practical uses of elective systemic (half-body) irradiation after 20 years of experimental designs
16. A phase I/II study to evaluate the effect of fractionated half-body irradiation in the treatment of osseous metastases RTOG 88-22
17. Brief summary of radiobiological principles in fractionated radiotherapy
18. Nonparametric estimation from incomplete observations
19. Asymptotically efficient rank invariant test procedures (with discussion)
20. Evaluation of survival data and two new rank order statistics arising in its consideration
21. Regression analysis using survival data
22. Fisher's test for 2 × 2 contingency tables
23. Radiation for bone metastases; Conventional techniques and the role of systemic radiopharmaceuticals
24. Radiotherapy for palliation of symptoms in incurable cancer
25. The effect of single fraction compared to multiple fractions on painful bone metastases; A global analysis of the Dutch bone metastases study
26. Brief courses of palliative radiotherapy for metastatic bone pain; A pilot cost-minimization comparison with narcotic analgesics
27. Use of strontium-89 in endocrine refractory prostate cancer metastatic to bone; Provincial Genitourinary Cancer Disease Site Group
28. Malignant bone pain; pathophysiology and treatment
29. The role of biophosphonates in the treatment of painful metastatic bone disease; A review of phase III trials
30. How can we improve the treatment of bone metastases further
31. Palliative radiotherapy in prostate cancer
32. Palliation of painful bone metastases; Strontium-89
33. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer
34. Bone pain palliation with 85-SR therapy
35. The treatment of osseous metastases of hormone-refractory prostate cancer with external beam radiotherapy and strontium-89
36. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases
37. Systemic half-body irradiation; A new dimension in oncology
38. Radiation therapy in the management of symptomatic bone metastases; The effect of total dose and histology on pain relief and response duration
39. Single-dose Radiation therapy for painful bony metastases
40. Pain relief and quality of life following radiotherapy for bone metastases; A randomized trial of two fractionation schedules